Literature DB >> 24949386

Heterotopic pancreas complicated by pseudocyst in the gastric wall diagnosed by endoscopic ultrasound-guided fine needle aspiration.

Haroldo Luís Oliva Gomes Rocha1, Fernanda Kistemarcker do Nascimento Bueno1, Jarbas Faraco1, Maurício Saab Assef1, Osvaldo Massatoshi Araki1, Frank Nakao1, Lucio Giovanni Bapttista Rossini1.   

Abstract

Heterotopic pancreas is usually asymptomatic and does not change throughout the patient's life, but sometimes it can present symp-toms and complications, which are rarely discrete in the literature. We present here a case of heterotopic pancreas in the gastric wall complicated with pseudocyst, and suggest that heterotopic pancreatic pseudocyst should be included in the differential diagnosis of gastric wall cysts.

Entities:  

Keywords:  endoscopic ultrasound; fine needle aspiration; gastric wall cyst; heterotopic pancreas; pancreatic cyst; pseudocyst

Year:  2013        PMID: 24949386      PMCID: PMC4062256          DOI: 10.7178/eus.06.009

Source DB:  PubMed          Journal:  Endosc Ultrasound        ISSN: 2226-7190            Impact factor:   5.628


INTRODUCTION

The term heterotopic pancreas is used to describe ectopic pancreatic tissue lying outside its normal location with no anatomic or vascular connection to the pancreas.1 These lesions are also termed ectopic pancreas, pancreatic rest, or aberrant pancreas. They are typically discovered incidentally during endoscopy, surgery, or autopsy.2 Its prevalence varies from 0.55% to 13.7%.345 The main location of heterotopic pancreas is in the stomach wall (frequently along the greater curvature of the antrum). Other locations are described in the literature: Duodenum, small intestine, or anywhere in the gastrointestinal tract.6 Endoscopic ultrasound (EUS) features of heterotopic pancreas are heterogeneous lesions, mainly hypoechoic or intermediate echogenic masses accompanied by scattered small hyperechoic areas, with indistinct margins within the gut wall. They commonly arise from the third and fourth layers.7 Usually, these lesions are asymptomatic and they do not change throughout the patient's life, but sometimes they can present symptoms. Complications are rarely described in the literature. This case report presents a case of heterotopic pancreas in the gastric wall, complicated by pseudocyst.

CASE REPORT

A 42-year-old male with chronic pancreatitis due to alcohol abuse presented with recurrent pain in the upper abdomen for the last 8 years, and progressive deterioration with the loss of 4 kg over the past 6 months. Other diseases are type 2 diabetes mellitus and exocrine pancreatic insufficiency. He takes pancreatic enzymes, insulin and omeprazole. On physical examination, the patient is emaciated and has pain in the epigastric region, with no palpable masses. In endoscopic examination performed to investigate abdominal pain, subepithelial lesion was found in the lesser curvature of the gastric body with normal mucosa. Patient was referred to perform EUS. EUS showed a cystic lesion of the gastric wall measuring 35 mm × 13 mm (Fig. 1), originating from the third layer, with anechoic contents and debris. Besides this, during the pancreatic EUS, heterogeneous pancreatic parenchyma and two cysts in the cephalic portion of the pancreas were accidentally found (Figs. 2 and 3). We perform fine-needle aspiration on the gastric wall cyst and also on the pancreatic head cyst. After emptying the gastric cyst, we observed a hypoechoic, heterogeneous residual lesion, with hyperechoic dots, suggestive of heterotopic pancreas in the third layer of the gastric wall. The material was sent for biochemical analysis, cytology, “cell block”, and bacteriological evaluation.
Figure 1

A and B: Endoscopic ultrasound shows a cystic lesion of the gastric wall

Figure 2

Endoscopic ultrasound shows the function of the cystic lesion

Figure 3

Endoscopic ultrasound shows the cystic lesion after the function

A and B: Endoscopic ultrasound shows a cystic lesion of the gastric wall Endoscopic ultrasound shows the function of the cystic lesion Endoscopic ultrasound shows the cystic lesion after the function The biochemical analysis of the content of the gastric wall cystic lesion showed amylase 62.075 U/L and carcinoembryonic antigen (CEA) 253.2 ng/mL and the content of the pancreatic cyst presented amylase 53.464 U/L and CEA 77.7 ng/mL. Both analyses showed negative neoplastic cells and negative cultures. After 3 weeks, patient continued to have abdominal pain and EUS re-evaluation of the gastric wall cyst shows the same characteristics as the first EUS, therefore, the final diagnosis was heterotopic pancreas with pseudocyst. The patient was treated with analgesics and continued to take pancreatic enzymes responding well to treatment, thus; no surgery was performed.

DISCUSSION

Patients with heterotopic pancreas are usually asymptomatic, but literature described rare complications such as pancreatitis, ulceration, bleeding, gastric outlet obstruction, obstructive jaundice, malignancy and pseudocyst formation.68910 Pseudocyst formation in heterotopic pancreas could result from retention of exocrine secretions in the absence of a communication between the glandular epithelium and the gastric lumen.11 Furthermore, the accumulation of pancreatic secretions can lead to recurrent episodes of acute obstructive pancreatitis and the formation of retention pseudocysts.12 In our case, the patient also showed changes in the pancreatic parenchyma caused by the toxic effect of alcohol. We believe that toxicity in pancreatic parenchyma caused by the effect of alcohol may have occurred in ectopic pancreatic tissue and led to the formation of the pseudocyst. In other studies, pathological examination of cystic lesions shows dilated ducts forming the pseudocysts and intense inflammation intermingled with heterotopic pancreas.131415 Cizginer et al.16 presents an optimal cutoff value of CEA 109.9 ng/mL, with 86% accuracy in predicting the mucinous cyst (P < 0.0001). However, other studies have cut of values for CEA 400 ng/mL and 800 ng/mL with specificity of 100% and 98% respectively in predicting mucinous cyst.1718 In this case, CEA 253.2 ng/mL was below 400 ng/mL. The cell block evaluation of the cystic lesion in the gastric wall was negative for neoplasia. The specificity varies from 55%19 to 97%20 for differentiating benign from malignant or potentially malignant pancreatic cystic lesions, and sensitivity of cytology is controversial in the literature. Almost all complications of heterotopic pancreas described in literature were treated with surgery.8910 Our patient has some comorbidities that increase the surgical risk, and we opted for conservative treatment. In conclusion, the heterotopic pancreas tissue can be affected by the same changes of the pancreatic parenchyma and may have complications such as pseudocyst formation. Heterotopic pancreatic pseudocyst should be included in the differential diagnosis of gastric wall cysts.
  19 in total

1.  [Heterotopic pancreatic cyst of the stomach wall].

Authors:  H Schmitz; F Spelsberg; M Janson
Journal:  Leber Magen Darm       Date:  1991-01

Review 2.  Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis.

Authors:  Laurens A van der Waaij; Hendrik M van Dullemen; Robert J Porte
Journal:  Gastrointest Endosc       Date:  2005-09       Impact factor: 9.427

3.  Case report: ectopic pancreas with pseudocyst and pseudoaneurysm formation.

Authors:  A Surov; M Hainz; L Hinz; H-J Holzhausen; R Finke; R-P Spielmann; C Kunze
Journal:  Clin Radiol       Date:  2009-04-22       Impact factor: 2.350

Review 4.  Pancreatic heterotopia: a reappraisal and clinicopathologic analysis of 32 cases.

Authors:  L C Pang
Journal:  South Med J       Date:  1988-10       Impact factor: 0.954

5.  Cyst fluid carcinoembryonic antigen is an accurate diagnostic marker of pancreatic mucinous cysts.

Authors:  Sevdenur Cizginer; Brian G Turner; Brian Turner; A Reyyan Bilge; Cetin Karaca; Martha B Pitman; William R Brugge
Journal:  Pancreas       Date:  2011-10       Impact factor: 3.327

6.  Heterotopic pancreatitis: gastric outlet obstruction due to an intramural pseudocyst and hamartoma.

Authors:  C F Eisenberger; A Kropp; T E Langwieler; A Gocht; J R Izbicki; W T Knoefel
Journal:  Z Gastroenterol       Date:  2002-04       Impact factor: 2.000

7.  Heterotopic pancreas presenting as gastric submucosal cyst on endoscopic sonography.

Authors:  Hsu-Heng Yen; Maw-Soan Soon; Anny Soon
Journal:  J Clin Ultrasound       Date:  2006-05       Impact factor: 0.910

8.  Diagnosis and therapeutic management of cystic dystrophy of the duodenal wall in heterotopic pancreas. A case report and revision of the literature.

Authors:  Giuseppe Galloro; Vincenzo Napolitano; Luca Magno; Giorgio Diamantis; Gerardo Nardone; Marika Bruno; Carmine Mollica; Giovanni Persico
Journal:  JOP       Date:  2008-11-03

9.  Cystic dystrophy of the gastric and duodenal wall developing in heterotopic pancreas: an unrecognised entity.

Authors:  J F Fléjou; F Potet; G Molas; P Bernades; P Amouyal; F Fékété
Journal:  Gut       Date:  1993-03       Impact factor: 23.059

10.  Ectopic pancreas: usual and unusual features.

Authors:  R F Thoeni; R K Gedgaudas
Journal:  Gastrointest Radiol       Date:  1980-02-01
View more
  2 in total

1.  Ectopic pancreas in the upper gastrointestinal tract: Is endosonographic diagnosis reliable? Data from the German Endoscopic Ultrasound Registry and review of the literature.

Authors:  Uwe Gottschalk; Christoph F Dietrich; Christian Jenssen
Journal:  Endosc Ultrasound       Date:  2018 Jul-Aug       Impact factor: 5.628

2.  Evaluation of transabdominal ultrasound after oral administration of an echoic cellulose-based gastric ultrasound contrast agent for gastric cancer.

Authors:  Zhijun Liu; Jintao Guo; Shupeng Wang; Ying Zhao; Jing Li; Weidong Ren; Shaoshan Tang; Limei Xie; Ying Huang; Siyu Sun; Liping Huang
Journal:  BMC Cancer       Date:  2015-11-25       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.